Global Vaccines Digital Biomanufacturing Market Growth (Status and Outlook) 2025-2031--LP INFORMATION, INC.

Global Vaccines Digital Biomanufacturing Market Growth (Status and Outlook) 2025-2031

Product Code: 1687968

Industry: Medical Care

Published: Jun 28,2025

Pages: 122

Delivery Time: 2-3 business days

Global Vaccines Digital Biomanufacturing Market Growth (Status and Outlook) 2025-2031

Product Code: 1687968

Industry: Medical Care

Published: Jun 28,2025

Pages: 122

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

According to this study, the global Vaccines Digital Biomanufacturing market size will reach US$ 1000 million by 2031.

Vaccines digital biomanufacturing refers to the integration of digital technologies (such as artificial intelligence, big data analytics, IoT, and modeling software) with biomanufacturing processes for vaccine production. It involves using digital tools to optimize each stage—from vaccine design and cell line development to fermentation, purification, and quality control—enabling real-time monitoring, predictive maintenance, and automated adjustment of production parameters. This approach enhances manufacturing efficiency, reduces costs, shortens production cycles, and improves scalability, particularly for rapid response to emerging pathogens or pandemic scenarios.

United States market for Vaccines Digital Biomanufacturing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Vaccines Digital Biomanufacturing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Vaccines Digital Biomanufacturing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Vaccines Digital Biomanufacturing players cover Cytiva (Danaher Corporation), Eppendorf SE, Sartorius AG, Merck KGaA, Aspen Technology Inc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Vaccines Digital Biomanufacturing Industry Forecast” looks at past sales and reviews total world Vaccines Digital Biomanufacturing sales in 2024, providing a comprehensive analysis by region and market sector of projected Vaccines Digital Biomanufacturing sales for 2025 through 2031. With Vaccines Digital Biomanufacturing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vaccines Digital Biomanufacturing industry.

This Insight Report provides a comprehensive analysis of the global Vaccines Digital Biomanufacturing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Vaccines Digital Biomanufacturing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vaccines Digital Biomanufacturing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vaccines Digital Biomanufacturing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vaccines Digital Biomanufacturing.

This report presents a comprehensive overview, market shares, and growth opportunities of Vaccines Digital Biomanufacturing market by product type, application, key players and key regions and countries.

Segmentation by Type:

    Manufacturing Execution System (MES)

    Process Analytical Technology (PAT)

    Data Analytics Software

    Digital Twins

Segmentation by Application:

    Biopharmaceutical Companies

    Contract Manufacturing Organizations

    Others

This report also splits the market by region:

    Americas

    United States

    Canada

    Mexico

    Brazil

    APAC

    China

    Japan

    Korea

    Southeast Asia

    India

    Australia

    Europe

    Germany

    France

UK

    Italy

    Russia

    Middle East & Africa

    Egypt

    South Africa

    Israel

    Turkey

    GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

    Cytiva (Danaher Corporation)

    Eppendorf SE

    Sartorius AG

    Merck KGaA

    Aspen Technology Inc

    Körber AG

    AmpleLogic

    Siemens

    Thermo Fisher Scientific Inc.

ABB

    Bruker

    Hamilton Company

    Dassault Systèmes

    Kymanox Corporation

    Invert, Inc.

    Genedata AG

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Vaccines Digital Biomanufacturing Market Size (2020-2031)
        2.1.2 Vaccines Digital Biomanufacturing Market Size CAGR by Region (2020 VS 2024 VS 2031)
        2.1.3 World Current & Future Analysis for Vaccines Digital Biomanufacturing by Country/Region (2020, 2024 & 2031)
    2.2 Vaccines Digital Biomanufacturing Segment by Type
        2.2.1 Manufacturing Execution System (MES)
        2.2.2 Process Analytical Technology (PAT)
        2.2.3 Data Analytics Software
        2.2.4 Digital Twins
    2.3 Vaccines Digital Biomanufacturing Market Size by Type
        2.3.1 Vaccines Digital Biomanufacturing Market Size CAGR by Type (2020 VS 2024 VS 2031)
        2.3.2 Global Vaccines Digital Biomanufacturing Market Size Market Share by Type (2020-2025)
    2.4 Vaccines Digital Biomanufacturing Segment by Application
        2.4.1 Biopharmaceutical Companies
        2.4.2 Contract Manufacturing Organizations
        2.4.3 Others
    2.5 Vaccines Digital Biomanufacturing Market Size by Application
        2.5.1 Vaccines Digital Biomanufacturing Market Size CAGR by Application (2020 VS 2024 VS 2031)
        2.5.2 Global Vaccines Digital Biomanufacturing Market Size Market Share by Application (2020-2025)

3 Vaccines Digital Biomanufacturing Market Size by Player
    3.1 Vaccines Digital Biomanufacturing Market Size Market Share by Player
        3.1.1 Global Vaccines Digital Biomanufacturing Revenue by Player (2020-2025)
        3.1.2 Global Vaccines Digital Biomanufacturing Revenue Market Share by Player (2020-2025)
    3.2 Global Vaccines Digital Biomanufacturing Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion

4 Vaccines Digital Biomanufacturing by Region
    4.1 Vaccines Digital Biomanufacturing Market Size by Region (2020-2025)
    4.2 Global Vaccines Digital Biomanufacturing Annual Revenue by Country/Region (2020-2025)
    4.3 Americas Vaccines Digital Biomanufacturing Market Size Growth (2020-2025)
    4.4 APAC Vaccines Digital Biomanufacturing Market Size Growth (2020-2025)
    4.5 Europe Vaccines Digital Biomanufacturing Market Size Growth (2020-2025)
    4.6 Middle East & Africa Vaccines Digital Biomanufacturing Market Size Growth (2020-2025)

5 Americas
    5.1 Americas Vaccines Digital Biomanufacturing Market Size by Country (2020-2025)
    5.2 Americas Vaccines Digital Biomanufacturing Market Size by Type (2020-2025)
    5.3 Americas Vaccines Digital Biomanufacturing Market Size by Application (2020-2025)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Vaccines Digital Biomanufacturing Market Size by Region (2020-2025)
    6.2 APAC Vaccines Digital Biomanufacturing Market Size by Type (2020-2025)
    6.3 APAC Vaccines Digital Biomanufacturing Market Size by Application (2020-2025)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia

7 Europe
    7.1 Europe Vaccines Digital Biomanufacturing Market Size by Country (2020-2025)
    7.2 Europe Vaccines Digital Biomanufacturing Market Size by Type (2020-2025)
    7.3 Europe Vaccines Digital Biomanufacturing Market Size by Application (2020-2025)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Vaccines Digital Biomanufacturing by Region (2020-2025)
    8.2 Middle East & Africa Vaccines Digital Biomanufacturing Market Size by Type (2020-2025)
    8.3 Middle East & Africa Vaccines Digital Biomanufacturing Market Size by Application (2020-2025)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Global Vaccines Digital Biomanufacturing Market Forecast
    10.1 Global Vaccines Digital Biomanufacturing Forecast by Region (2026-2031)
        10.1.1 Global Vaccines Digital Biomanufacturing Forecast by Region (2026-2031)
        10.1.2 Americas Vaccines Digital Biomanufacturing Forecast
        10.1.3 APAC Vaccines Digital Biomanufacturing Forecast
        10.1.4 Europe Vaccines Digital Biomanufacturing Forecast
        10.1.5 Middle East & Africa Vaccines Digital Biomanufacturing Forecast
    10.2 Americas Vaccines Digital Biomanufacturing Forecast by Country (2026-2031)
        10.2.1 United States Market Vaccines Digital Biomanufacturing Forecast
        10.2.2 Canada Market Vaccines Digital Biomanufacturing Forecast
        10.2.3 Mexico Market Vaccines Digital Biomanufacturing Forecast
        10.2.4 Brazil Market Vaccines Digital Biomanufacturing Forecast
    10.3 APAC Vaccines Digital Biomanufacturing Forecast by Region (2026-2031)
        10.3.1 China Vaccines Digital Biomanufacturing Market Forecast
        10.3.2 Japan Market Vaccines Digital Biomanufacturing Forecast
        10.3.3 Korea Market Vaccines Digital Biomanufacturing Forecast
        10.3.4 Southeast Asia Market Vaccines Digital Biomanufacturing Forecast
        10.3.5 India Market Vaccines Digital Biomanufacturing Forecast
        10.3.6 Australia Market Vaccines Digital Biomanufacturing Forecast
    10.4 Europe Vaccines Digital Biomanufacturing Forecast by Country (2026-2031)
        10.4.1 Germany Market Vaccines Digital Biomanufacturing Forecast
        10.4.2 France Market Vaccines Digital Biomanufacturing Forecast
        10.4.3 UK Market Vaccines Digital Biomanufacturing Forecast
        10.4.4 Italy Market Vaccines Digital Biomanufacturing Forecast
        10.4.5 Russia Market Vaccines Digital Biomanufacturing Forecast
    10.5 Middle East & Africa Vaccines Digital Biomanufacturing Forecast by Region (2026-2031)
        10.5.1 Egypt Market Vaccines Digital Biomanufacturing Forecast
        10.5.2 South Africa Market Vaccines Digital Biomanufacturing Forecast
        10.5.3 Israel Market Vaccines Digital Biomanufacturing Forecast
        10.5.4 Turkey Market Vaccines Digital Biomanufacturing Forecast
    10.6 Global Vaccines Digital Biomanufacturing Forecast by Type (2026-2031)
    10.7 Global Vaccines Digital Biomanufacturing Forecast by Application (2026-2031)
        10.7.1 GCC Countries Market Vaccines Digital Biomanufacturing Forecast

11 Key Players Analysis
    11.1 Cytiva (Danaher Corporation)
        11.1.1 Cytiva (Danaher Corporation) Company Information
        11.1.2 Cytiva (Danaher Corporation) Vaccines Digital Biomanufacturing Product Offered
        11.1.3 Cytiva (Danaher Corporation) Vaccines Digital Biomanufacturing Revenue, Gross Margin and Market Share (2020-2025)
        11.1.4 Cytiva (Danaher Corporation) Main Business Overview
        11.1.5 Cytiva (Danaher Corporation) Latest Developments
    11.2 Eppendorf SE
        11.2.1 Eppendorf SE Company Information
        11.2.2 Eppendorf SE Vaccines Digital Biomanufacturing Product Offered
        11.2.3 Eppendorf SE Vaccines Digital Biomanufacturing Revenue, Gross Margin and Market Share (2020-2025)
        11.2.4 Eppendorf SE Main Business Overview
        11.2.5 Eppendorf SE Latest Developments
    11.3 Sartorius AG
        11.3.1 Sartorius AG Company Information
        11.3.2 Sartorius AG Vaccines Digital Biomanufacturing Product Offered
        11.3.3 Sartorius AG Vaccines Digital Biomanufacturing Revenue, Gross Margin and Market Share (2020-2025)
        11.3.4 Sartorius AG Main Business Overview
        11.3.5 Sartorius AG Latest Developments
    11.4 Merck KGaA
        11.4.1 Merck KGaA Company Information
        11.4.2 Merck KGaA Vaccines Digital Biomanufacturing Product Offered
        11.4.3 Merck KGaA Vaccines Digital Biomanufacturing Revenue, Gross Margin and Market Share (2020-2025)
        11.4.4 Merck KGaA Main Business Overview
        11.4.5 Merck KGaA Latest Developments
    11.5 Aspen Technology Inc
        11.5.1 Aspen Technology Inc Company Information
        11.5.2 Aspen Technology Inc Vaccines Digital Biomanufacturing Product Offered
        11.5.3 Aspen Technology Inc Vaccines Digital Biomanufacturing Revenue, Gross Margin and Market Share (2020-2025)
        11.5.4 Aspen Technology Inc Main Business Overview
        11.5.5 Aspen Technology Inc Latest Developments
    11.6 Körber AG
        11.6.1 Körber AG Company Information
        11.6.2 Körber AG Vaccines Digital Biomanufacturing Product Offered
        11.6.3 Körber AG Vaccines Digital Biomanufacturing Revenue, Gross Margin and Market Share (2020-2025)
        11.6.4 Körber AG Main Business Overview
        11.6.5 Körber AG Latest Developments
    11.7 AmpleLogic
        11.7.1 AmpleLogic Company Information
        11.7.2 AmpleLogic Vaccines Digital Biomanufacturing Product Offered
        11.7.3 AmpleLogic Vaccines Digital Biomanufacturing Revenue, Gross Margin and Market Share (2020-2025)
        11.7.4 AmpleLogic Main Business Overview
        11.7.5 AmpleLogic Latest Developments
    11.8 Siemens
        11.8.1 Siemens Company Information
        11.8.2 Siemens Vaccines Digital Biomanufacturing Product Offered
        11.8.3 Siemens Vaccines Digital Biomanufacturing Revenue, Gross Margin and Market Share (2020-2025)
        11.8.4 Siemens Main Business Overview
        11.8.5 Siemens Latest Developments
    11.9 Thermo Fisher Scientific Inc.
        11.9.1 Thermo Fisher Scientific Inc. Company Information
        11.9.2 Thermo Fisher Scientific Inc. Vaccines Digital Biomanufacturing Product Offered
        11.9.3 Thermo Fisher Scientific Inc. Vaccines Digital Biomanufacturing Revenue, Gross Margin and Market Share (2020-2025)
        11.9.4 Thermo Fisher Scientific Inc. Main Business Overview
        11.9.5 Thermo Fisher Scientific Inc. Latest Developments
    11.10 ABB
        11.10.1 ABB Company Information
        11.10.2 ABB Vaccines Digital Biomanufacturing Product Offered
        11.10.3 ABB Vaccines Digital Biomanufacturing Revenue, Gross Margin and Market Share (2020-2025)
        11.10.4 ABB Main Business Overview
        11.10.5 ABB Latest Developments
    11.11 Bruker
        11.11.1 Bruker Company Information
        11.11.2 Bruker Vaccines Digital Biomanufacturing Product Offered
        11.11.3 Bruker Vaccines Digital Biomanufacturing Revenue, Gross Margin and Market Share (2020-2025)
        11.11.4 Bruker Main Business Overview
        11.11.5 Bruker Latest Developments
    11.12 Hamilton Company
        11.12.1 Hamilton Company Company Information
        11.12.2 Hamilton Company Vaccines Digital Biomanufacturing Product Offered
        11.12.3 Hamilton Company Vaccines Digital Biomanufacturing Revenue, Gross Margin and Market Share (2020-2025)
        11.12.4 Hamilton Company Main Business Overview
        11.12.5 Hamilton Company Latest Developments
    11.13 Dassault Systèmes
        11.13.1 Dassault Systèmes Company Information
        11.13.2 Dassault Systèmes Vaccines Digital Biomanufacturing Product Offered
        11.13.3 Dassault Systèmes Vaccines Digital Biomanufacturing Revenue, Gross Margin and Market Share (2020-2025)
        11.13.4 Dassault Systèmes Main Business Overview
        11.13.5 Dassault Systèmes Latest Developments
    11.14 Kymanox Corporation
        11.14.1 Kymanox Corporation Company Information
        11.14.2 Kymanox Corporation Vaccines Digital Biomanufacturing Product Offered
        11.14.3 Kymanox Corporation Vaccines Digital Biomanufacturing Revenue, Gross Margin and Market Share (2020-2025)
        11.14.4 Kymanox Corporation Main Business Overview
        11.14.5 Kymanox Corporation Latest Developments
    11.15 Invert, Inc.
        11.15.1 Invert, Inc. Company Information
        11.15.2 Invert, Inc. Vaccines Digital Biomanufacturing Product Offered
        11.15.3 Invert, Inc. Vaccines Digital Biomanufacturing Revenue, Gross Margin and Market Share (2020-2025)
        11.15.4 Invert, Inc. Main Business Overview
        11.15.5 Invert, Inc. Latest Developments
    11.16 Genedata AG
        11.16.1 Genedata AG Company Information
        11.16.2 Genedata AG Vaccines Digital Biomanufacturing Product Offered
        11.16.3 Genedata AG Vaccines Digital Biomanufacturing Revenue, Gross Margin and Market Share (2020-2025)
        11.16.4 Genedata AG Main Business Overview
        11.16.5 Genedata AG Latest Developments

12 Research Findings and Conclusion

List Of Tables

List of Tables
 Table 1. Vaccines Digital Biomanufacturing Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
 Table 2. Vaccines Digital Biomanufacturing Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
 Table 3. Major Players of Manufacturing Execution System (MES)
 Table 4. Major Players of Process Analytical Technology (PAT)
 Table 5. Major Players of Data Analytics Software
 Table 6. Major Players of Digital Twins
 Table 7. Vaccines Digital Biomanufacturing Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
 Table 8. Global Vaccines Digital Biomanufacturing Market Size by Type (2020-2025) & ($ millions)
 Table 9. Global Vaccines Digital Biomanufacturing Market Size Market Share by Type (2020-2025)
 Table 10. Vaccines Digital Biomanufacturing Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
 Table 11. Global Vaccines Digital Biomanufacturing Market Size by Application (2020-2025) & ($ millions)
 Table 12. Global Vaccines Digital Biomanufacturing Market Size Market Share by Application (2020-2025)
 Table 13. Global Vaccines Digital Biomanufacturing Revenue by Player (2020-2025) & ($ millions)
 Table 14. Global Vaccines Digital Biomanufacturing Revenue Market Share by Player (2020-2025)
 Table 15. Vaccines Digital Biomanufacturing Key Players Head office and Products Offered
 Table 16. Vaccines Digital Biomanufacturing Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
 Table 17. New Products and Potential Entrants
 Table 18. Mergers & Acquisitions, Expansion
 Table 19. Global Vaccines Digital Biomanufacturing Market Size by Region (2020-2025) & ($ millions)
 Table 20. Global Vaccines Digital Biomanufacturing Market Size Market Share by Region (2020-2025)
 Table 21. Global Vaccines Digital Biomanufacturing Revenue by Country/Region (2020-2025) & ($ millions)
 Table 22. Global Vaccines Digital Biomanufacturing Revenue Market Share by Country/Region (2020-2025)
 Table 23. Americas Vaccines Digital Biomanufacturing Market Size by Country (2020-2025) & ($ millions)
 Table 24. Americas Vaccines Digital Biomanufacturing Market Size Market Share by Country (2020-2025)
 Table 25. Americas Vaccines Digital Biomanufacturing Market Size by Type (2020-2025) & ($ millions)
 Table 26. Americas Vaccines Digital Biomanufacturing Market Size Market Share by Type (2020-2025)
 Table 27. Americas Vaccines Digital Biomanufacturing Market Size by Application (2020-2025) & ($ millions)
 Table 28. Americas Vaccines Digital Biomanufacturing Market Size Market Share by Application (2020-2025)
 Table 29. APAC Vaccines Digital Biomanufacturing Market Size by Region (2020-2025) & ($ millions)
 Table 30. APAC Vaccines Digital Biomanufacturing Market Size Market Share by Region (2020-2025)
 Table 31. APAC Vaccines Digital Biomanufacturing Market Size by Type (2020-2025) & ($ millions)
 Table 32. APAC Vaccines Digital Biomanufacturing Market Size by Application (2020-2025) & ($ millions)
 Table 33. Europe Vaccines Digital Biomanufacturing Market Size by Country (2020-2025) & ($ millions)
 Table 34. Europe Vaccines Digital Biomanufacturing Market Size Market Share by Country (2020-2025)
 Table 35. Europe Vaccines Digital Biomanufacturing Market Size by Type (2020-2025) & ($ millions)
 Table 36. Europe Vaccines Digital Biomanufacturing Market Size by Application (2020-2025) & ($ millions)
 Table 37. Middle East & Africa Vaccines Digital Biomanufacturing Market Size by Region (2020-2025) & ($ millions)
 Table 38. Middle East & Africa Vaccines Digital Biomanufacturing Market Size by Type (2020-2025) & ($ millions)
 Table 39. Middle East & Africa Vaccines Digital Biomanufacturing Market Size by Application (2020-2025) & ($ millions)
 Table 40. Key Market Drivers & Growth Opportunities of Vaccines Digital Biomanufacturing
 Table 41. Key Market Challenges & Risks of Vaccines Digital Biomanufacturing
 Table 42. Key Industry Trends of Vaccines Digital Biomanufacturing
 Table 43. Global Vaccines Digital Biomanufacturing Market Size Forecast by Region (2026-2031) & ($ millions)
 Table 44. Global Vaccines Digital Biomanufacturing Market Size Market Share Forecast by Region (2026-2031)
 Table 45. Global Vaccines Digital Biomanufacturing Market Size Forecast by Type (2026-2031) & ($ millions)
 Table 46. Global Vaccines Digital Biomanufacturing Market Size Forecast by Application (2026-2031) & ($ millions)
 Table 47. Cytiva (Danaher Corporation) Details, Company Type, Vaccines Digital Biomanufacturing Area Served and Its Competitors
 Table 48. Cytiva (Danaher Corporation) Vaccines Digital Biomanufacturing Product Offered
 Table 49. Cytiva (Danaher Corporation) Vaccines Digital Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 50. Cytiva (Danaher Corporation) Main Business
 Table 51. Cytiva (Danaher Corporation) Latest Developments
 Table 52. Eppendorf SE Details, Company Type, Vaccines Digital Biomanufacturing Area Served and Its Competitors
 Table 53. Eppendorf SE Vaccines Digital Biomanufacturing Product Offered
 Table 54. Eppendorf SE Vaccines Digital Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 55. Eppendorf SE Main Business
 Table 56. Eppendorf SE Latest Developments
 Table 57. Sartorius AG Details, Company Type, Vaccines Digital Biomanufacturing Area Served and Its Competitors
 Table 58. Sartorius AG Vaccines Digital Biomanufacturing Product Offered
 Table 59. Sartorius AG Vaccines Digital Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 60. Sartorius AG Main Business
 Table 61. Sartorius AG Latest Developments
 Table 62. Merck KGaA Details, Company Type, Vaccines Digital Biomanufacturing Area Served and Its Competitors
 Table 63. Merck KGaA Vaccines Digital Biomanufacturing Product Offered
 Table 64. Merck KGaA Vaccines Digital Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 65. Merck KGaA Main Business
 Table 66. Merck KGaA Latest Developments
 Table 67. Aspen Technology Inc Details, Company Type, Vaccines Digital Biomanufacturing Area Served and Its Competitors
 Table 68. Aspen Technology Inc Vaccines Digital Biomanufacturing Product Offered
 Table 69. Aspen Technology Inc Vaccines Digital Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 70. Aspen Technology Inc Main Business
 Table 71. Aspen Technology Inc Latest Developments
 Table 72. Körber AG Details, Company Type, Vaccines Digital Biomanufacturing Area Served and Its Competitors
 Table 73. Körber AG Vaccines Digital Biomanufacturing Product Offered
 Table 74. Körber AG Vaccines Digital Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 75. Körber AG Main Business
 Table 76. Körber AG Latest Developments
 Table 77. AmpleLogic Details, Company Type, Vaccines Digital Biomanufacturing Area Served and Its Competitors
 Table 78. AmpleLogic Vaccines Digital Biomanufacturing Product Offered
 Table 79. AmpleLogic Vaccines Digital Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 80. AmpleLogic Main Business
 Table 81. AmpleLogic Latest Developments
 Table 82. Siemens Details, Company Type, Vaccines Digital Biomanufacturing Area Served and Its Competitors
 Table 83. Siemens Vaccines Digital Biomanufacturing Product Offered
 Table 84. Siemens Vaccines Digital Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 85. Siemens Main Business
 Table 86. Siemens Latest Developments
 Table 87. Thermo Fisher Scientific Inc. Details, Company Type, Vaccines Digital Biomanufacturing Area Served and Its Competitors
 Table 88. Thermo Fisher Scientific Inc. Vaccines Digital Biomanufacturing Product Offered
 Table 89. Thermo Fisher Scientific Inc. Vaccines Digital Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 90. Thermo Fisher Scientific Inc. Main Business
 Table 91. Thermo Fisher Scientific Inc. Latest Developments
 Table 92. ABB Details, Company Type, Vaccines Digital Biomanufacturing Area Served and Its Competitors
 Table 93. ABB Vaccines Digital Biomanufacturing Product Offered
 Table 94. ABB Vaccines Digital Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 95. ABB Main Business
 Table 96. ABB Latest Developments
 Table 97. Bruker Details, Company Type, Vaccines Digital Biomanufacturing Area Served and Its Competitors
 Table 98. Bruker Vaccines Digital Biomanufacturing Product Offered
 Table 99. Bruker Vaccines Digital Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 100. Bruker Main Business
 Table 101. Bruker Latest Developments
 Table 102. Hamilton Company Details, Company Type, Vaccines Digital Biomanufacturing Area Served and Its Competitors
 Table 103. Hamilton Company Vaccines Digital Biomanufacturing Product Offered
 Table 104. Hamilton Company Vaccines Digital Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 105. Hamilton Company Main Business
 Table 106. Hamilton Company Latest Developments
 Table 107. Dassault Systèmes Details, Company Type, Vaccines Digital Biomanufacturing Area Served and Its Competitors
 Table 108. Dassault Systèmes Vaccines Digital Biomanufacturing Product Offered
 Table 109. Dassault Systèmes Vaccines Digital Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 110. Dassault Systèmes Main Business
 Table 111. Dassault Systèmes Latest Developments
 Table 112. Kymanox Corporation Details, Company Type, Vaccines Digital Biomanufacturing Area Served and Its Competitors
 Table 113. Kymanox Corporation Vaccines Digital Biomanufacturing Product Offered
 Table 114. Kymanox Corporation Vaccines Digital Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 115. Kymanox Corporation Main Business
 Table 116. Kymanox Corporation Latest Developments
 Table 117. Invert, Inc. Details, Company Type, Vaccines Digital Biomanufacturing Area Served and Its Competitors
 Table 118. Invert, Inc. Vaccines Digital Biomanufacturing Product Offered
 Table 119. Invert, Inc. Vaccines Digital Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 120. Invert, Inc. Main Business
 Table 121. Invert, Inc. Latest Developments
 Table 122. Genedata AG Details, Company Type, Vaccines Digital Biomanufacturing Area Served and Its Competitors
 Table 123. Genedata AG Vaccines Digital Biomanufacturing Product Offered
 Table 124. Genedata AG Vaccines Digital Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 125. Genedata AG Main Business
 Table 126. Genedata AG Latest Developments


List of Figures
 Figure 1. Vaccines Digital Biomanufacturing Report Years Considered
 Figure 2. Research Objectives
 Figure 3. Research Methodology
 Figure 4. Research Process and Data Source
 Figure 5. Global Vaccines Digital Biomanufacturing Market Size Growth Rate (2020-2031) ($ millions)
 Figure 6. Vaccines Digital Biomanufacturing Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Figure 7. Vaccines Digital Biomanufacturing Sales Market Share by Country/Region (2024)
 Figure 8. Vaccines Digital Biomanufacturing Sales Market Share by Country/Region (2020, 2024 & 2031)
 Figure 9. Global Vaccines Digital Biomanufacturing Market Size Market Share by Type in 2024
 Figure 10. Vaccines Digital Biomanufacturing in Biopharmaceutical Companies
 Figure 11. Global Vaccines Digital Biomanufacturing Market: Biopharmaceutical Companies (2020-2025) & ($ millions)
 Figure 12. Vaccines Digital Biomanufacturing in Contract Manufacturing Organizations
 Figure 13. Global Vaccines Digital Biomanufacturing Market: Contract Manufacturing Organizations (2020-2025) & ($ millions)
 Figure 14. Vaccines Digital Biomanufacturing in Others
 Figure 15. Global Vaccines Digital Biomanufacturing Market: Others (2020-2025) & ($ millions)
 Figure 16. Global Vaccines Digital Biomanufacturing Market Size Market Share by Application in 2024
 Figure 17. Global Vaccines Digital Biomanufacturing Revenue Market Share by Player in 2024
 Figure 18. Global Vaccines Digital Biomanufacturing Market Size Market Share by Region (2020-2025)
 Figure 19. Americas Vaccines Digital Biomanufacturing Market Size 2020-2025 ($ millions)
 Figure 20. APAC Vaccines Digital Biomanufacturing Market Size 2020-2025 ($ millions)
 Figure 21. Europe Vaccines Digital Biomanufacturing Market Size 2020-2025 ($ millions)
 Figure 22. Middle East & Africa Vaccines Digital Biomanufacturing Market Size 2020-2025 ($ millions)
 Figure 23. Americas Vaccines Digital Biomanufacturing Value Market Share by Country in 2024
 Figure 24. United States Vaccines Digital Biomanufacturing Market Size Growth 2020-2025 ($ millions)
 Figure 25. Canada Vaccines Digital Biomanufacturing Market Size Growth 2020-2025 ($ millions)
 Figure 26. Mexico Vaccines Digital Biomanufacturing Market Size Growth 2020-2025 ($ millions)
 Figure 27. Brazil Vaccines Digital Biomanufacturing Market Size Growth 2020-2025 ($ millions)
 Figure 28. APAC Vaccines Digital Biomanufacturing Market Size Market Share by Region in 2024
 Figure 29. APAC Vaccines Digital Biomanufacturing Market Size Market Share by Type (2020-2025)
 Figure 30. APAC Vaccines Digital Biomanufacturing Market Size Market Share by Application (2020-2025)
 Figure 31. China Vaccines Digital Biomanufacturing Market Size Growth 2020-2025 ($ millions)
 Figure 32. Japan Vaccines Digital Biomanufacturing Market Size Growth 2020-2025 ($ millions)
 Figure 33. South Korea Vaccines Digital Biomanufacturing Market Size Growth 2020-2025 ($ millions)
 Figure 34. Southeast Asia Vaccines Digital Biomanufacturing Market Size Growth 2020-2025 ($ millions)
 Figure 35. India Vaccines Digital Biomanufacturing Market Size Growth 2020-2025 ($ millions)
 Figure 36. Australia Vaccines Digital Biomanufacturing Market Size Growth 2020-2025 ($ millions)
 Figure 37. Europe Vaccines Digital Biomanufacturing Market Size Market Share by Country in 2024
 Figure 38. Europe Vaccines Digital Biomanufacturing Market Size Market Share by Type (2020-2025)
 Figure 39. Europe Vaccines Digital Biomanufacturing Market Size Market Share by Application (2020-2025)
 Figure 40. Germany Vaccines Digital Biomanufacturing Market Size Growth 2020-2025 ($ millions)
 Figure 41. France Vaccines Digital Biomanufacturing Market Size Growth 2020-2025 ($ millions)
 Figure 42. UK Vaccines Digital Biomanufacturing Market Size Growth 2020-2025 ($ millions)
 Figure 43. Italy Vaccines Digital Biomanufacturing Market Size Growth 2020-2025 ($ millions)
 Figure 44. Russia Vaccines Digital Biomanufacturing Market Size Growth 2020-2025 ($ millions)
 Figure 45. Middle East & Africa Vaccines Digital Biomanufacturing Market Size Market Share by Region (2020-2025)
 Figure 46. Middle East & Africa Vaccines Digital Biomanufacturing Market Size Market Share by Type (2020-2025)
 Figure 47. Middle East & Africa Vaccines Digital Biomanufacturing Market Size Market Share by Application (2020-2025)
 Figure 48. Egypt Vaccines Digital Biomanufacturing Market Size Growth 2020-2025 ($ millions)
 Figure 49. South Africa Vaccines Digital Biomanufacturing Market Size Growth 2020-2025 ($ millions)
 Figure 50. Israel Vaccines Digital Biomanufacturing Market Size Growth 2020-2025 ($ millions)
 Figure 51. Turkey Vaccines Digital Biomanufacturing Market Size Growth 2020-2025 ($ millions)
 Figure 52. GCC Countries Vaccines Digital Biomanufacturing Market Size Growth 2020-2025 ($ millions)
 Figure 53. Americas Vaccines Digital Biomanufacturing Market Size 2026-2031 ($ millions)
 Figure 54. APAC Vaccines Digital Biomanufacturing Market Size 2026-2031 ($ millions)
 Figure 55. Europe Vaccines Digital Biomanufacturing Market Size 2026-2031 ($ millions)
 Figure 56. Middle East & Africa Vaccines Digital Biomanufacturing Market Size 2026-2031 ($ millions)
 Figure 57. United States Vaccines Digital Biomanufacturing Market Size 2026-2031 ($ millions)
 Figure 58. Canada Vaccines Digital Biomanufacturing Market Size 2026-2031 ($ millions)
 Figure 59. Mexico Vaccines Digital Biomanufacturing Market Size 2026-2031 ($ millions)
 Figure 60. Brazil Vaccines Digital Biomanufacturing Market Size 2026-2031 ($ millions)
 Figure 61. China Vaccines Digital Biomanufacturing Market Size 2026-2031 ($ millions)
 Figure 62. Japan Vaccines Digital Biomanufacturing Market Size 2026-2031 ($ millions)
 Figure 63. Korea Vaccines Digital Biomanufacturing Market Size 2026-2031 ($ millions)
 Figure 64. Southeast Asia Vaccines Digital Biomanufacturing Market Size 2026-2031 ($ millions)
 Figure 65. India Vaccines Digital Biomanufacturing Market Size 2026-2031 ($ millions)
 Figure 66. Australia Vaccines Digital Biomanufacturing Market Size 2026-2031 ($ millions)
 Figure 67. Germany Vaccines Digital Biomanufacturing Market Size 2026-2031 ($ millions)
 Figure 68. France Vaccines Digital Biomanufacturing Market Size 2026-2031 ($ millions)
 Figure 69. UK Vaccines Digital Biomanufacturing Market Size 2026-2031 ($ millions)
 Figure 70. Italy Vaccines Digital Biomanufacturing Market Size 2026-2031 ($ millions)
 Figure 71. Russia Vaccines Digital Biomanufacturing Market Size 2026-2031 ($ millions)
 Figure 72. Egypt Vaccines Digital Biomanufacturing Market Size 2026-2031 ($ millions)
 Figure 73. South Africa Vaccines Digital Biomanufacturing Market Size 2026-2031 ($ millions)
 Figure 74. Israel Vaccines Digital Biomanufacturing Market Size 2026-2031 ($ millions)
 Figure 75. Turkey Vaccines Digital Biomanufacturing Market Size 2026-2031 ($ millions)
 Figure 76. Global Vaccines Digital Biomanufacturing Market Size Market Share Forecast by Type (2026-2031)
 Figure 77. Global Vaccines Digital Biomanufacturing Market Size Market Share Forecast by Application (2026-2031)
 Figure 78. GCC Countries Vaccines Digital Biomanufacturing Market Size 2026-2031 ($ millions)

Companies Mentioned

Cytiva (Danaher Corporation)

Eppendorf SE

Sartorius AG

Merck KGaA

Aspen Technology Inc

Körber AG

AmpleLogic

Siemens

Thermo Fisher Scientific Inc.

ABB

Bruker

Hamilton Company

Dassault Systèmes

Kymanox Corporation

Invert, Inc.

Genedata AG

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff